239 related articles for article (PubMed ID: 21890814)
21. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
[TBL] [Abstract][Full Text] [Related]
22. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
[TBL] [Abstract][Full Text] [Related]
23. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
24. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
[TBL] [Abstract][Full Text] [Related]
25. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
26. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.
Schatzkin A; Lanza E; Corle D; Lance P; Iber F; Caan B; Shike M; Weissfeld J; Burt R; Cooper MR; Kikendall JW; Cahill J
N Engl J Med; 2000 Apr; 342(16):1149-55. PubMed ID: 10770979
[TBL] [Abstract][Full Text] [Related]
27. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
[TBL] [Abstract][Full Text] [Related]
28. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials.
Gao F; Liao C; Liu L; Tan A; Cao Y; Mo Z
Colorectal Dis; 2009 Nov; 11(9):893-901. PubMed ID: 19055515
[TBL] [Abstract][Full Text] [Related]
29. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).
Tangrea JA; Albert PS; Lanza E; Woodson K; Corle D; Hasson M; Burt R; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A;
Cancer Causes Control; 2003 Jun; 14(5):403-11. PubMed ID: 12946034
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
31. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.
Lanas A; Baron JA; Sandler RS; Horgan K; Bolognese J; Oxenius B; Quan H; Watson D; Cook TJ; Schoen R; Burke C; Loftus S; Niv Y; Ridell R; Morton D; Bresalier R
Gastroenterology; 2007 Feb; 132(2):490-7. PubMed ID: 17258718
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib for the prevention of sporadic colorectal adenomas.
Bertagnolli MM; Eagle CJ; Zauber AG; Redston M; Solomon SD; Kim K; Tang J; Rosenstein RB; Wittes J; Corle D; Hess TM; Woloj GM; Boisserie F; Anderson WF; Viner JL; Bagheri D; Burn J; Chung DC; Dewar T; Foley TR; Hoffman N; Macrae F; Pruitt RE; Saltzman JR; Salzberg B; Sylwestrowicz T; Gordon GB; Hawk ET;
N Engl J Med; 2006 Aug; 355(9):873-84. PubMed ID: 16943400
[TBL] [Abstract][Full Text] [Related]
33. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
Kim S; Baron JA; Mott LA; Burke CA; Church TR; McKeown-Eyssen GE; Cole BF; Haile RW; Sandler RS
Cancer Causes Control; 2006 Dec; 17(10):1299-304. PubMed ID: 17111262
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
[TBL] [Abstract][Full Text] [Related]
35. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.
Alberts DS; Martínez ME; Roe DJ; Guillén-Rodríguez JM; Marshall JR; van Leeuwen JB; Reid ME; Ritenbaugh C; Vargas PA; Bhattacharyya AB; Earnest DL; Sampliner RE
N Engl J Med; 2000 Apr; 342(16):1156-62. PubMed ID: 10770980
[TBL] [Abstract][Full Text] [Related]
36. A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.
Puntoni M; Branchi D; Argusti A; Zanardi S; Crosta C; Meroni E; Munizzi F; Michetti P; Coccia G; De Roberto G; Bandelloni R; Turbino L; Minetti E; Mori M; Salvi S; Boccardo S; Gatteschi B; Benelli R; Sonzogni A; DeCensi A
Cancer Prev Res (Phila); 2013 Feb; 6(2):74-81. PubMed ID: 23213070
[TBL] [Abstract][Full Text] [Related]
37. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
[TBL] [Abstract][Full Text] [Related]
38. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
Solomon SD; McMurray JJ; Pfeffer MA; Wittes J; Fowler R; Finn P; Anderson WF; Zauber A; Hawk E; Bertagnolli M;
N Engl J Med; 2005 Mar; 352(11):1071-80. PubMed ID: 15713944
[TBL] [Abstract][Full Text] [Related]
40. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial.
Parikh AA; Scadding GK
Laryngoscope; 2005 Aug; 115(8):1385-90. PubMed ID: 16094110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
